|
|
| | ELTROMBOPAG Basic information |
| Product Name: | ELTROMBOPAG | | Synonyms: | Benzoic acid, 3-[5-[2-[1-(3,4-dimethylphenyl)-2,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]hydrazinylidene]-6-oxo-1,3-cyclohexadien-1-yl]- | | CAS: | 1807882-48-9 | | MF: | C25H22N4O4 | | MW: | 442.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1807882-48-9.mol |  |
| | ELTROMBOPAG Chemical Properties |
| Boiling point | 687.0±65.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 3.95±0.10(Predicted) |
| | ELTROMBOPAG Usage And Synthesis |
| Definition | ChEBI: Eltrombopag is a hydrazine in which each nitrogen atom is substituted, one by a 3'-carboxy-2-hydroxy[1,1'-biphenyl]-3-yl group and the other by a 1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene group. A small molecule agonist of the c-mpl (TpoR) receptor (the physiological target of the hormone thrombopoietin), it has been developed as a medication for conditions that lead to thrombocytopenia (abnormally low platelet counts). It has a role as a thrombopoietin receptor agonist and a xenobiotic. It is a member of hydrazines, a member of pyrazoles and a member of benzoic acids. |
| | ELTROMBOPAG Preparation Products And Raw materials |
|